Omkar Speciality Chemicals is currently trading at Rs. 167.30, up by 1.00 points or 0.60% from its previous closing of Rs. 166.30 on the BSE.
The scrip opened at Rs. 163.40 and has touched a high and low of Rs. 169.00 and Rs. 163.40 respectively. So far 2,958 shares were traded on the counter.
The BSE group 'B ' stock of face value Rs. 10 has touched a 52 week high of Rs. 249.10 on 13-Jan-2016 and a 52 week low of Rs. 138.00 on 30-Apr-2015.
Last one week high and low of the scrip stood at Rs. 174.50 and Rs. 163.40 respectively. The current market cap of the company is Rs. 344.27 crore.
The promoters holding in the company stood at 65.77% while Institutions and Non-Institutions held 10.72% and 23.51% respectively.
Omkar Speciality Chemicals has incorporated a Wholly Owned Subsidiary (WOS) company, ‘LASA Supergenerics’, which is registered with the Registrar of Companies, Mumbai on March 11, 2016. LASA Supergenerics is incorporated to manufacture, produce, or to otherwise deal in chemicals, organic and inorganic chemicals, their byproducts, pharmaceuticals, drugs and other related products.
Omkar Speciality Chemicals is primarily engaged in the production of Speciality Chemicals and Pharma Intermediates. The company manufactures a range of Organic, Inorganic and Organo Inorganic Intermediates. The Inorganic Intermediates include Molybdenum derivatives, Selenium derivatives, Iodine derivatives, Cobalt derivatives, Bismuth & Tungsten derivatives and the organic intermediates include Tartaric acid derivatives and other intermediates.
| Company Name | CMP |
|---|---|
| BASF India | 3703.10 |
| Tata Chemicals | 709.05 |
| SRF | 2493.65 |
| Pidilite Inds. | 1393.25 |
| Deepak Nitrite | 1538.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: